fashion -WSS

fashion

author：focus 2025-10-01 23:57:22 - browse：8964

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Surge of respiratory disease in China has likely explanation

WSS

Dogs on Prozac: What pet anti

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

UnitedHealth financials solid despite Change Healthcare cyberattack

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

MultiPlan and major insurers sued for alleged medical price

Wikipedia

fashion

entertainment

Drug repurposing or repositioning? The language matters

Diversity in clinical trials starts with building trust, experts say

Duchenne breakthrough therapy leaves behind pioneering families

Why medical students are struggling with mental health

Anesthesiologist group: stop taking Ozempic before surgery

Morphosys mixed study results for blood cancer drug

Anesthesiologist group: stop taking Ozempic before surgery

Key Senate committee drafts bipartisan bill to stem drug shortages

Anesthesiologist group: stop taking Ozempic before surgery

Health care needs a new profession: neuroimaging counseling

focus

World's first CRISPR

Gain of function research would be limited under House proposal

CRISPR pioneers react to Casgevy, first gene

Cell therapy fails to slow type 1 diabetes, but safety is established

PBM reforms clear House panel

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

explore

knowledge

explore

hotspot